COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS

Rhea-AI Summary

CollPlant Biotechnologies (Nasdaq: CLGN) said it will report full-year 2025 financial results on Thursday, March 26, 2026, before the opening of U.S. financial markets. The announcement sets a date for earnings disclosure and signals when investors can expect results and related company materials.

News Market Reaction – CLGN

-1.63%

1 alert

-1.63% Session close to close

$8.69M Market Cap

0.2x Rel. Volume

In the Mar 11 session, CLGN declined 1.63%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets March 26, 2026, as the date for full-year 2025 financial results, giving a cl...

Analysis

This announcement sets March 26, 2026, as the date for full-year 2025 financial results, giving a clear timeline for the next major update. It follows recent product launches, IP wins, and a $2.0M offering that reshaped the balance sheet. Investors may focus on revenue growth, cash position, and cost controls, as well as updates on rhCollagen-based aesthetics and bioprinting initiatives, when those detailed results and commentary are released.

Key Figures

Earnings release date: March 26, 2026

1 metrics

Earnings release date March 26, 2026 Full-year 2025 financial results scheduled before U.S. market open

Previous Earnings date Reports

1 past event · Latest: Nov 18 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Nov 18	Earnings date notice	Neutral	+0.9%	Set reporting date for Q3 2025 results before U.S. market open.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Past earnings date scheduling news led to a small positive move of 0.94%, suggesting such announcements have historically had limited but slightly positive impact.

Recent Company History

This announcement schedules CollPlant’s full-year 2025 results after a period of active corporate developments. In late 2025, the company reported Q3 results with revenue growth, AbbVie milestone income, cash of $8.5M, and a ~25% workforce reduction. Early 2026 brought multiple product and IP updates plus a $2.0M registered direct offering that triggered a significant selloff. Compared with those events, today’s earnings date notice is procedural but sets the timeline for the next major financial update on March 26, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REHOVOT, Israel, March 11, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for medical aesthetics and tissue regeneration, today announced that it will report financial results for the full year of 2025 on Thursday, March 26, 2026, before the opening of the U.S. financial markets.

About CollPlant

CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on medical aesthetics and 3D bioprinting of tissues and organs. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.

In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.

For more information about CollPlant, visit http://www.collplant.com

Contacts

CollPlant:                                                                           
Eran Rotem                                                                         
Deputy CEO & CFO                                                                     
Tel: +972-73-2325600                                                       
Email: eran@collplant.com             

Logo - https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-date-for-full-year-2025-financial-results-302710906.html

SOURCE CollPlant

FAQ

When will CollPlant (CLGN) report full-year 2025 financial results?

CollPlant will report full-year 2025 financial results on Thursday, March 26, 2026, before U.S. markets open. According to CollPlant, the timing gives investors an early-day release window and will be followed by earnings materials and any investor call or webcast details.

What time of day will CollPlant (CLGN) release its March 26, 2026 results?

Results will be released before the opening of U.S. financial markets on March 26, 2026. According to CollPlant, a pre-market release allows investors time to review financials ahead of trading and typically precedes an earnings presentation or conference call.

Where can investors access CollPlant (CLGN) full-year 2025 results and materials?

Investors can access results via CollPlant's investor relations channels and Nasdaq filings on March 26, 2026. According to CollPlant, the company will publish earnings materials and may provide a webcast or conference call link for further context and Q&A.

Will CollPlant (CLGN) hold a conference call or webcast with the March 26, 2026 results?

The company indicated results will be released before markets open, with investor materials to follow and potential event details. According to CollPlant, any conference call or webcast information will be posted alongside the financial release for shareholder access.

How should shareholders prepare for CollPlant's (CLGN) March 26, 2026 earnings release?

Shareholders should review the scheduled release date and plan to check CollPlant's investor page and Nasdaq filings on March 26, 2026. According to CollPlant, earnings materials and any event access details will be posted with the financial results for review.

What does the March 26, 2026 reporting date mean for CLGN stock trading?

The pre-market release may cause intraday volatility once markets open on March 26, 2026, as investors digest results. According to CollPlant, the announcement simply sets the reporting timetable; market reaction will depend on the disclosed financial details and guidance.